magnolol has been researched along with rhein in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Liu, Y; Song, R; Tian, Y; Xu, F; Zhang, Z | 1 |
| Bian, BL; Fan, MX; Li, PY; Li, XM; Wang, HJ | 1 |
| Chen, GY; Gong, HL; Huang, X; Liang, MZ; Tang, WF; Xia, Q; Xiang, J; Yu, Q | 1 |
| Dong, H; Liu, Y; Song, R; Xu, F; Zhang, Z | 1 |
| Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J | 1 |
| Chen, G; Gong, H; Tang, W; Wang, J; Xiang, J; Zhao, J | 1 |
| Li, J; Li, JY; Ren, HY; Su, H; Tang, WF; Wu, FS; Zhang, YM; Zhao, XL | 1 |
| Chen, J; Li, D; Lv, B; Qin, S; Wang, D; Xu, D; Xu, F; Zhang, W; Zhang, Y; Zhang, Z | 1 |
8 other study(ies) available for magnolol and rhein
| Article | Year |
|---|---|
Rapid simultaneous quantification of five active constituents in rat plasma by high-performance liquid chromatography/tandem mass spectrometry after oral administration of Da-Cheng-Qi decoction.
Topics: Administration, Oral; Animals; Anthraquinones; Biphenyl Compounds; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Emodin; Female; Lignans; Male; Plant Extracts; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2008 |
[Studies on chemical constituents and volatile oil of Xiaochengqi decoction].
Topics: Anthraquinones; Biphenyl Compounds; Cinnamates; Cyclohexenes; Cymenes; Drugs, Chinese Herbal; Emodin; Gallic Acid; Gas Chromatography-Mass Spectrometry; Lignans; Limonene; Monoterpenes; Oils, Volatile; Sitosterols; Terpenes | 2008 |
Effect of severe acute pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Enzyme Inhibitors; Flavanones; Glucosides; Hesperidin; Humans; Lignans; Male; Molecular Structure; Mutagens; Pancreatitis, Acute Necrotizing; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley | 2009 |
Pharmacokinetic comparison in rats of six bioactive compounds between Da-Cheng-Qi decoction and its parent herbal medicines.
Topics: Animals; Anthraquinones; Area Under Curve; Biphenyl Compounds; Chromatography, Liquid; Drugs, Chinese Herbal; Emodin; Female; Flavanones; Hesperidin; Lignans; Male; Plant Extracts; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2010 |
Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Topics: Administration, Oral; Animals; Anthraquinones; Biphenyl Compounds; Drug Incompatibility; Emodin; Flavanones; Hesperidin; Lignans; Male; Plant Extracts; Rats; Rats, Sprague-Dawley | 2012 |
Pharmacokinetic and pharmacodynamic studies of four major phytochemical components of Da-Cheng-Qi decoction to treat acute pancreatitis.
Topics: Animals; Anthraquinones; Apoptosis; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Flavanones; Hesperidin; Lignans; Male; Necrosis; Pancreas; Pancreatitis, Acute Necrotizing; Phytotherapy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2013 |
Pharmacokinetics and pharmacodynamics of Da-Cheng-Qi decoction in the liver of rats with severe acute pancreatitis.
Topics: Acute Disease; Alanine Transaminase; Animals; Anthraquinones; Aspartate Aminotransferases; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Emodin; Flavanones; Hesperidin; Inflammation; Lignans; Liver; Male; Pancreatitis; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2017 |
Network Pharmacology and Bioactive Equivalence Assessment Integrated Strategy Driven Q-markers Discovery for Da-Cheng-Qi Decoction to Attenuate Intestinal Obstruction.
Topics: Algorithms; Animals; Anthraquinones; Biomarkers, Pharmacological; Biphenyl Compounds; Data Mining; Drugs, Chinese Herbal; Flavanones; HT29 Cells; Humans; Intestinal Obstruction; Lignans; Male; Phosphatidylinositol 3-Kinases; Rats, Sprague-Dawley; Reproducibility of Results; Therapeutic Equivalency | 2020 |